comparemela.com

Latest Breaking News On - Grand pharmaceutical group limited - Page 1 : comparemela.com

Telix reports fourth consecutive quarter of positive operating cash flow

/PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow report and accompanying.

Switzerland
China
Australia
Brazil
Canada
Melbourne
Victoria
United-states
United-kingdom
Japan
Belgium
New-zealand

Telix 2023 Half-Year Results: Revenue and Earnings Growth Marks Transition to a Sustainable Commercial-Stage Company

/PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its financial results for the half-year ended 30 June 2023. All.

Australia
Canada
Switzerland
United-states
China
Belgium
United-kingdom
Melbourne
Victoria
Brussels
Bruxelles-capitale
Japan

Telix Pharmaceuticals Limited: First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients

Telix Pharmaceuticals Limited: First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Japan
Melbourne
Victoria
Australia
United-states
Switzerland
United-kingdom
China
Canada
Belgium
Dingwei
Fujian

First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients

First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
United-kingdom
Yong-he
Anhui
China
Japan
Belgium
Melbourne
Victoria
Australia
Dingwei
Fujian

First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix) for Prostate Cancer Imaging in Chinese Patients

First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix) for Prostate Cancer Imaging in Chinese Patients
malaysiasun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from malaysiasun.com Daily Mail and Mail on Sunday newspapers.

Switzerland
United-states
China
Australia
United-kingdom
Belgium
Dingwei
Fujian
Canada
Melbourne
Victoria
Japan
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.